From January 1, 2024 to March 18, 2024, the company has repurchased 286,400 shares, representing 0.16% for CNY 8.92 million. With this, the company has completed the repurchase of 1,285,600 shares, representing 0.71% for CNY 39.9 million under the buyback announced on September 15, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.98 CNY | +4.35% | +3.37% | +24.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.00% | 1.03B | |
+20.87% | 8.44B | |
+7.54% | 7.78B | |
+12.95% | 6.77B | |
-4.42% | 3.81B | |
-5.81% | 3.71B | |
+2.08% | 1.4B | |
-26.15% | 1.09B | |
-11.23% | 901M | |
-17.24% | 785M |
- Stock Market
- Equities
- 300791 Stock
- News Sirio Pharma Co., Ltd.
- Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.